Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial

Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial

Abstract Background There are limited efficacious treatment options for severe osteoarthritis of the knee (OAK). The Low Molecular Weight Fraction of 5% human serum Albumin (LMWF-5A) is in development to treat severe OAK. This study evaluated the safety and efficacy of LMWF-5A for the signs and symp...

Full description

Bibliographic Details
Main Authors: Kristin Salottolo, Brian Cole, David Bar-Or
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Patient Safety in Surgery
Subjects:
Safety
Efficacy
Osteoarthritis
Intra-articular injection
Online Access:http://link.springer.com/article/10.1186/s13037-018-0158-0

Internet

http://link.springer.com/article/10.1186/s13037-018-0158-0

Similar Items